---

title: Atrial Fibrillation and Anticoagulation
collection:
  - Cardiovascular
tags: aspirin, warfarin

---

# Atrial Fibrillation and Anticoagulation

-   Anticoagulation goal with <span class="drug">warfarin</span>: INR 2-3
-   If age &lt; 60 years and zero risk factors: No anticoagulation b/c low risk for CVA 

**Deciding on whether to anticoagulate with aspirin or warfarin:**

## Weak Risk Factors

- Female gender    
- Age 65-74         
- CAD               
- Thyrotoxicosis

**Treatment**

- <span class="drug">warfarin</span> or <span class="drug">warfarin</span>

## Moderate Risk Factors

- Age &gt; 75            
- HTN                     
- Heart failure           
- LVEF ≤ 35%              
- DM  

**Treatment**

- 1 Risk factor: <span class="drug">aspirin</span> or <span class="drug">warfarin</span>
- &gt; 1 Risk factor: <span class="drug">warfarin</span>

## High Risk Factors

- Prior CVA        
- Prior TIA         
- Embolism          
- Mitral stenosis   
- Mech heart valve

**Treatment**

- <span class="drug">warfarin</span>

([AHA/ACC/ESC 2006 guidelines](http://circ.ahajournals.org/content/114/7/e257.full))

## Background

**Atrial Fibrillation** (AF) = **5x** risk for CVA and increases with age 

-   Patients with persistent and paroxysmal atrial fibrillation should be treated the same when it comes to deciding about anticoagulation. They have an equivalent risk of stroke.

**Stroke risk factors for patients with AF: **

-   Prior CVA or TIA
-   HTN
-   Age ≥75
-   CHF
-   Poor LV function
-   DM

## CHADS2 stroke risk stratification scheme 

-   **C** = Congestive heart failure (1 pt)
-   **H** = Hypertension (1 pt)
-   **A **= Age ≥ 75 (1 pt)
-   **D **= DM (1 pt)
-   **S2** = prior Stroke or TIA (2 pts)

![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/41833411-397e-52ca-866b-0fe62dacc52e/640.png)
([Gage et al., JAMA, 2001](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607))

## References

-   [ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation](http://circ.ahajournals.org/content/114/7/e257.full)
-   [Waldo AL. Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation. Cardiol Clin 2009; 27:125-35.](https://www.ncbi.nlm.nih.gov/pubmed/?term=19111769)
-   [Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70.](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607)
